ASSOCIATION OF HISTOLOGIC MEASUREMENT WITH ENDOSCOPIC OUTCOMES AFTER ONE YEAR OF TREATMENT WITH MIRIKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE

Fernando Magro  ¹     Gert De Hertogh  ²     Marijana Protic  ³     Lai Shan Chan  ³     Paul Pollack  ³     Brian G. Feagan  ⁴     Noam Harpaz  ⁵     Rish Pai  ⁶     Walter Reinisch  ^7    
1 University Hospital São João, Porto, Portugal
² University Hospital Leuven, Leuven, Belgium
³ Eli Lilly and Company, Indianapolis, United States
⁴ Robarts Clinical Trials Inc., London, Canada
⁵ Icahn School of Medicine at Mount Sinai, New York City, United States
⁶ Mayo Clinic, Scottdale, United States
⁷ Medical University of Vienna, Wien, Austria

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)